A table that shows the results of a trial for Halaven Fycompa and Investigative Lenvatinib. The table is divided into six columns each representing a different country.
The first column is for Russia the second column is from Brazil the third column is in Mexico and the fourth column is to Canada. The first column has the names of the countries that have been approved for 2nd line treatment for metastatic breast cancer in November 2014. The second column has "Launched in September 2014" and "Submitted in December 2014". The third column has a list of countries that are approved in November 2015. The fourth column has two countries Brazil and Mexico with the first country being Brazil and the second country being Mexico.
At the bottom of the table there is a note that reads "Australia" and the third country is Australia. The note also mentions that the trial was launched in October 2014 and that the trials were submitted in December 2015. There is also a note on the right side of the image that says "Orphan drug designation granted in November 2016".
Description 
Type
Category
Source 1 of 3
-
Date
2015
Collection
-
Date
2015
Collection
-
Date
2015
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
